PAVmed Inc. (PAVM) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the POP Quarter 2026 Business Update Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session following the prepared remarks. To require operator assistance, please press 4-0. Please note, this event is being recorded. I would not like to turn the conference call over to Matt Riley, Huffman's Vice President of Investor Relations. Please go ahead. Thank you, operator, and good morning, everyone. Thank you for participating in today's business update call. Joining me today on the call are Dr. Elishan Akhlaq, Chairman and Chief Executive Officer of PatMed, along with Dennis McGrath, Chief Financial Officer of PatMed. The press release announcing our business update and financial results is available on PatMed's website. Please take a moment to read the disclaimers about board-looking statements in the press release. The business update, press release, and conference call all include board-looking statements And these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings of the SEC. For a list and a description of these and other important risks and uncertainties that may affect future operations, see Part 1, Item 1A, entitled Risk Factors in PAVMED's most recent annual report on Forms 10-K. filed with the FCC, and any subsequent updates filed in the court reports on Forms 10-Q and subsequent Forms 8-K. Acceptance required by law has not displayed any intentions or obligations to publicly update or revise any four-dozen statements to reflect the changes in expectations on events, c...